Following the granting of a marketing authorisation, the authorisation holder may allow use to be made of the pharmaceutical, pre-clinical and clinical documentation contained in the file on the medicinal product, with a view to examining subsequent applications relating to other medicinal products possessing the same qualitative and quantitative composition in terms of active substances and the same pharmaceutical form.
Art. 10c Directive (EU) 2001/83
The 10 that are cited most themselves, of 11.
Judgment of the Court (Fifth Chamber), 23 October 2014. Olainfarm AS v Latvijas Republikas Veselības ministrija and Zāļu valsts aģentūra.Decision
… 8 odst. 3, články 10a, 10b nebo 10c směrnice 2001/83.
23 Oct 2014 · 62013CJ0104
Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…35Law
… předklinické a klinické podklady obsažené v registrační dokumentaci léčivého přípravku na základě článku 10c směrnice 2001/83/ES. Držitel registrace informuje agenturu o svých záměrech zastavit uvedení přípravku na …
Judgment of the Court (Second Chamber) of 14 March 2018. Proceedings brought by Astellas Pharma GmbH.Decision
Article 19(1) of Directive 2001/83 provides that, in order to examine the application submitted in accordance with Articles 8, 10, 10a, 10b and 10c, the competent authority of a Member State must verify whether the particulars submitted in …
14 Mar 2018 · 62016CJ0557
Opinion of Advocate General Wahl delivered on 20 May 2014. Olainfarm AS v Latvijas Republikas Veselības ministrija and Zāļu valsts aģentūra.Decision
Existuje však několik výjimek z uvedeného pravidla [Tyto výjimky jsou obsaženy v článcích 10, 10a, 10b, a 10c směrnice 2001/83. V následujících bodech posoudím pouze výjimky stanovené v článcích 10 a 10a, neboť pouze ty …
20 May 2014 · 62013CC0104
Opinion of Mr Advocate General Mazák delivered on 26 March 2009. The Queen, on the application of Generics (UK) Ltd v Licensing Authority.Decision
… 8 odst. 3, články 10a, 10b nebo 10c směrnice 2001/83“ [Kapitola 1, oddíl 5.3.1., zvýraznění provedeno autorem tohoto stanoviska.].
26 Mar 2009 · 62007CC0527
Council Regulation (EC) No 1905/2005 of 14 November 2005 amending Regulation (EC) No 297…1Law
… fee of EUR 90 000 shall apply to applications for a marketing authorisation pursuant to Article 10(1) and (3), and Article 10c of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code …
Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision
Thus, according to Article 30(1) of Directive 2001/83, if two or more applications submitted in accordance with Articles 8, 10, 10a, 10b, 10c and 11 of that directive have been made for marketing authorisation for a particular medicinal …
5 May 2021 · 62018TJ0611
… d’autorisation de mise sur le marché d’un médicament fondées sur un consentement éclairé visée à l’article 10 quater de la directive 2001/83/CE. Cette redevance couvre tous les dosages, toutes les formes pharmaceutiques et …
Opinion of Advocate General Kokott delivered on 4 October 2018. Staat der Nederlanden v Warner-Lambert Company LLC.Decision
… kan […] suspenderes, tilbagekaldes eller ændres, hvis de oplysninger, der i henhold til artikel 8, 10, 10a, 10b, 10c eller 11 er anført i sagens akter, er urigtige […]«.
4 Oct 2018 · 62017CC0423
Opinion of Mr Advocate General Bot delivered on 24 May 2007. Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische GDecision
… 1, skal godkendes og etiketteres i overensstemmelse med artikel 8 og artikel 10, 10a, 10b, 10c og 11«. Denne bestemmelse indebærer, at homøopatiske lægemidler, som ikke opfylder alle betingelserne i direktivets artikel 14, stk. 1, og …
24 May 2007 · 62006CC0084
- 26 Jan 2007 – todayin force
- 30 Apr 2004 – 26 Jan 2007earlier wording
Versions are held from 6 Nov 2001; the article may be older.